Background & Sources: What documentation supports a Zantac Cancer injury claim

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Featured analysis

What documentation supports a Zantac Cancer injury claim — Background & Analysis

A focused review of background, context, and source material on this subject.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.